Login to Your Account

Sweden Bolstering Research Despite an Uncertain Climate

By Cormac Sheridan
Staff Writer

Wednesday, November 28, 2012
STOCKHOLM & UPPSALA, Sweden – The scaling up of university-based drug discovery research in the Stockholm-Uppsala region, just as AstraZeneca plc is exiting from that same activity, neatly encapsulates an industry trend that has created both headaches and opportunities for Europe's leading bioscience research centers.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription